Copyright
©The Author(s) 2015.
World J Gastroenterol. Dec 28, 2015; 21(48): 13566-13573
Published online Dec 28, 2015. doi: 10.3748/wjg.v21.i48.13566
Published online Dec 28, 2015. doi: 10.3748/wjg.v21.i48.13566
Table 1 Clinical characteristics of the 88 inflammatory bowel disease patients n (%)
UC (n = 52) | CD (n = 36) | |
Gender (M/F) | 34/18 | 19/17 |
Age (yr) | 44 (17-76) | 34 (21-71) |
Disease extent/location | ||
E1/L1 | 13 (25) | 4 (11) |
E2/L2 | 15 (29) | 8 (22) |
E3/L3 | 24 (46) | 24 (67) |
EIS [median (IQR)] | 3 (1-4) | 8 (5.2-21) |
Calprotectin (μg/g) [median (IQR)] | 447 (116-1700) | 309 (100-1130) |
CRP [median (IQR)] | 0.17 (0.04-0.51) | 0.15 (0.05-0.91) |
- Citation: Lin WC, Wong JM, Tung CC, Lin CP, Chou JW, Wang HY, Shieh MJ, Chang CH, Liu HH, Wei SC, Taiwan Society of Inflammatory Bowel Disease Multicenter Study. Fecal calprotectin correlated with endoscopic remission for Asian inflammatory bowel disease patients. World J Gastroenterol 2015; 21(48): 13566-13573
- URL: https://www.wjgnet.com/1007-9327/full/v21/i48/13566.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i48.13566